hims and hers tirzepatide & Expands Weight Loss Offering, Adds Lilly's Zepbound to Platform Hims & Hers debuts $199

Some women find that menstrual patterns stabilise once weight loss plateaus or slows, as the body adapts to the new metabolic state

A 2025 analysis by GoodRx found that 62% of commercial plans cover at least one GLP-1 for weight loss, but only 18% cover both Wegovy and Zepbound without prior authorization

A shadowy market for weight-loss drugs has emerged online Shortages and big price tags have driven patients to unconventional sources of GLP-1 drugs In late 2022, pharmacist Joseph Lambson got an unusual call from a poison control specialist

It also helps in proper circulation of oxygen to all body tissues

The gap between petri-dish results and real-world human faces is larger than marketing suggests

Your clinician will evaluate your current dosage, tolerance, and medical history to determine the safest and most appropriate transition plan for your body